Global Dermatological Drugs Market 2014-2018

世界の皮膚適用薬市場動向(2014-2018)

◆タイトル:Global Dermatological Drugs Market 2014-2018
◆商品コード:IRTNTR3361
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年3月7日
◆ページ数:68
◆資料形式:pdf / 英語
◆納品方法:Email
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥308,000見積依頼/購入/質問フォーム
Global License(社内共有可)USD10,000 ⇒換算¥1,100,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の皮膚適用薬市場動向(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、種類別分析、主要地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

TechNavio’s analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market’s growth is an increase in the aging population worldwide. The Global Dermatological Drugs market has also been witnessing a spurt in the use of biologics. However, the risk of adverse side effects associated with dermatological drugs could pose a challenge to the growth of this market.
TechNavio’s report, the Global Dermatological Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Dermatological Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include AbbVie Inc., Galderma S.A., Johnson & Johnson Ltd., Novartis AG, Stiefel Laboratories Inc., and Valeant Pharmaceuticals International Inc.
Other vendors mentioned in the report are Actavis plc, Allergan Inc., Almirall SA, Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol Myers Squibb Co., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., Genentech Inc., Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., Mylan Pharmaceuticals Inc., Pfizer Inc., and UCB SA.
Key questions answered in this report:
What will the market size and growth rate be in 2018?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Global Psoriasis Drugs Market
06.3.1 Market Size and Forecast
06.4 Global Acne Drugs Market
06.4.1 Market Size and Forecast
06.5 Global Dermatitis Drugs Market
06.5.1 Market Size and Forecast
06.6 Five Forces Analysis
07. Market Segmentation by Type
08. Geographical Segmentation
09. Buying Criteria
10. Rate of Incidence and Prevalence
Global Incidence and Prevalence of Psoriasis
Global Incidence and Prevalence of Acne
Global Incidence and Prevalence of Dermatitis
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbvie Inc.
18.1.1 Business Overview
18.1.2 Key Information
18.1.3 SWOT Analysis
18.2 Galderma S.A.
18.2.1 Business Overview
18.2.2 Key Information
18.2.3 SWOT Analysis
18.3 Johnson & Johnson Ltd.
18.3.1 Business Overview
18.3.2 Business Segmentation
18.3.3 Key Information
18.3.4 SWOT Analysis
18.4 Novartis International AG
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis
18.5 Stiefel Laboratories Inc.
18.5.1 Business Overview
18.5.2 Key Information
18.5.3 SWOT Analysis
18.6 Valeant Pharmaceuticals International Inc.
18.6.1 Business Overview
18.6.2 Business Segmentation
18.6.3 Key Information
18.6.4 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Dermatological Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Psoriasis Drugs Market 2013-2018 (US$ billion)
Exhibit 4: Global Acne Drugs Market 2013-2018 (US$ billion)
Exhibit 5: Global Dermatitis Drugs Market 2013-2018 (US$ billion)
Exhibit 6: Global Dermatological Drugs Market by Segmentation (revenue)
Exhibit 7: Global Dermatological Drugs Market by Segmentation (percentage)
Exhibit 8: Comparison of YOY Growth Rates among various Market Segments in Global Dermatological Drugs Market
Exhibit 9: Global Dermatological Drugs Market Segmentation by Types
Exhibit 10: Global Dermatological Drugs Market by Type 2013 (in percent)
Exhibit 11: Global Dermatological Drugs Market by Geographical Segmentation 2013
Exhibit 12: Business Segmentation of Johnson & Johnson Ltd.
Exhibit 13: Business Segmentation of Novartis AG
Exhibit 14: Business Segmentation of Valeant Pharmaceuticals International Inc.



【掲載企業】

AbbVie Inc., Galderma S.A., Johnson & Johnson Ltd., Novartis AG, Stiefel Laboratories Inc., Valeant Pharmaceuticals International Inc., Actavis plc, Allergan Inc., Almirall SA, Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol Myers Squibb Co., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., Genentech Inc., Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., Mylan Pharmaceuticals Inc., Pfizer Inc., and UCB SA.



【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界の皮膚適用薬市場動向(2014-2018)] (Global Dermatological Drugs Market 2014-2018 / IRTNTR3361)販売に関する免責事項
[世界の皮膚適用薬市場動向(2014-2018)] (Global Dermatological Drugs Market 2014-2018 / IRTNTR3361)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆